Anti-fungal Agents Market 2028 by Drug Type, Therapeutic Indication, Dosage form and Geography | The Insight Partners

Anti-fungal Agents Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Drug Type (Echinocandins, Azoles, Polyenes, Allylamines); Therapeutic Indication (Aspergillosis, Dermatophytosis, Candidiasis, Others); Dosage form (Powder, Ointment, Drugs, Other) and Geography

Report Code: TIPRE00008775 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anti-fungal Agents Market - By Drug Type
1.3.2 Anti-fungal Agents Market - By Therapeutic Indication
1.3.3 Anti-fungal Agents Market - By Dosage form
1.3.4 Anti-fungal Agents Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ANTI-FUNGAL AGENTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ANTI-FUNGAL AGENTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. ANTI-FUNGAL AGENTS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTI-FUNGAL AGENTS - GLOBAL MARKET OVERVIEW
6.2. ANTI-FUNGAL AGENTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. ANTI-FUNGAL AGENTS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. ECHINOCANDINS
7.3.1. Overview
7.3.2. Echinocandins Market Forecast and Analysis
7.4. AZOLES
7.4.1. Overview
7.4.2. Azoles Market Forecast and Analysis
7.5. POLYENES
7.5.1. Overview
7.5.2. Polyenes Market Forecast and Analysis
7.6. ALLYLAMINES
7.6.1. Overview
7.6.2. Allylamines Market Forecast and Analysis
8. ANTI-FUNGAL AGENTS MARKET - REVENUE AND FORECASTS TO 2028 - THERAPEUTIC INDICATION
8.1. OVERVIEW
8.2. THERAPEUTIC INDICATION MARKET FORECASTS AND ANALYSIS
8.3. ASPERGILLOSIS
8.3.1. Overview
8.3.2. Aspergillosis Market Forecast and Analysis
8.4. DERMATOPHYTOSIS
8.4.1. Overview
8.4.2. Dermatophytosis Market Forecast and Analysis
8.5. CANDIDIASIS
8.5.1. Overview
8.5.2. Candidiasis Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. others Market Forecast and Analysis
9. ANTI-FUNGAL AGENTS MARKET - REVENUE AND FORECASTS TO 2028 - DOSAGE FORM
9.1. OVERVIEW
9.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS
9.3. POWDER
9.3.1. Overview
9.3.2. Powder Market Forecast and Analysis
9.4. OINTMENT
9.4.1. Overview
9.4.2. Ointment Market Forecast and Analysis
9.5. DRUGS
9.5.1. Overview
9.5.2. Drugs Market Forecast and Analysis
9.6. OTHER
9.6.1. Overview
9.6.2. Other Market Forecast and Analysis

10. ANTI-FUNGAL AGENTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Anti-fungal Agents Market Overview
10.1.2 North America Anti-fungal Agents Market Forecasts and Analysis
10.1.3 North America Anti-fungal Agents Market Forecasts and Analysis - By Drug Type
10.1.4 North America Anti-fungal Agents Market Forecasts and Analysis - By Therapeutic Indication
10.1.5 North America Anti-fungal Agents Market Forecasts and Analysis - By Dosage form
10.1.6 North America Anti-fungal Agents Market Forecasts and Analysis - By Countries
10.1.6.1 United States Anti-fungal Agents Market
10.1.6.1.1 United States Anti-fungal Agents Market by Drug Type
10.1.6.1.2 United States Anti-fungal Agents Market by Therapeutic Indication
10.1.6.1.3 United States Anti-fungal Agents Market by Dosage form
10.1.6.2 Canada Anti-fungal Agents Market
10.1.6.2.1 Canada Anti-fungal Agents Market by Drug Type
10.1.6.2.2 Canada Anti-fungal Agents Market by Therapeutic Indication
10.1.6.2.3 Canada Anti-fungal Agents Market by Dosage form
10.1.6.3 Mexico Anti-fungal Agents Market
10.1.6.3.1 Mexico Anti-fungal Agents Market by Drug Type
10.1.6.3.2 Mexico Anti-fungal Agents Market by Therapeutic Indication
10.1.6.3.3 Mexico Anti-fungal Agents Market by Dosage form
10.2. EUROPE
10.2.1 Europe Anti-fungal Agents Market Overview
10.2.2 Europe Anti-fungal Agents Market Forecasts and Analysis
10.2.3 Europe Anti-fungal Agents Market Forecasts and Analysis - By Drug Type
10.2.4 Europe Anti-fungal Agents Market Forecasts and Analysis - By Therapeutic Indication
10.2.5 Europe Anti-fungal Agents Market Forecasts and Analysis - By Dosage form
10.2.6 Europe Anti-fungal Agents Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Anti-fungal Agents Market
10.2.6.1.1 Germany Anti-fungal Agents Market by Drug Type
10.2.6.1.2 Germany Anti-fungal Agents Market by Therapeutic Indication
10.2.6.1.3 Germany Anti-fungal Agents Market by Dosage form
10.2.6.2 France Anti-fungal Agents Market
10.2.6.2.1 France Anti-fungal Agents Market by Drug Type
10.2.6.2.2 France Anti-fungal Agents Market by Therapeutic Indication
10.2.6.2.3 France Anti-fungal Agents Market by Dosage form
10.2.6.3 Italy Anti-fungal Agents Market
10.2.6.3.1 Italy Anti-fungal Agents Market by Drug Type
10.2.6.3.2 Italy Anti-fungal Agents Market by Therapeutic Indication
10.2.6.3.3 Italy Anti-fungal Agents Market by Dosage form
10.2.6.4 Spain Anti-fungal Agents Market
10.2.6.4.1 Spain Anti-fungal Agents Market by Drug Type
10.2.6.4.2 Spain Anti-fungal Agents Market by Therapeutic Indication
10.2.6.4.3 Spain Anti-fungal Agents Market by Dosage form
10.2.6.5 United Kingdom Anti-fungal Agents Market
10.2.6.5.1 United Kingdom Anti-fungal Agents Market by Drug Type
10.2.6.5.2 United Kingdom Anti-fungal Agents Market by Therapeutic Indication
10.2.6.5.3 United Kingdom Anti-fungal Agents Market by Dosage form
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Anti-fungal Agents Market Overview
10.3.2 Asia-Pacific Anti-fungal Agents Market Forecasts and Analysis
10.3.3 Asia-Pacific Anti-fungal Agents Market Forecasts and Analysis - By Drug Type
10.3.4 Asia-Pacific Anti-fungal Agents Market Forecasts and Analysis - By Therapeutic Indication
10.3.5 Asia-Pacific Anti-fungal Agents Market Forecasts and Analysis - By Dosage form
10.3.6 Asia-Pacific Anti-fungal Agents Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Anti-fungal Agents Market
10.3.6.1.1 Australia Anti-fungal Agents Market by Drug Type
10.3.6.1.2 Australia Anti-fungal Agents Market by Therapeutic Indication
10.3.6.1.3 Australia Anti-fungal Agents Market by Dosage form
10.3.6.2 China Anti-fungal Agents Market
10.3.6.2.1 China Anti-fungal Agents Market by Drug Type
10.3.6.2.2 China Anti-fungal Agents Market by Therapeutic Indication
10.3.6.2.3 China Anti-fungal Agents Market by Dosage form
10.3.6.3 India Anti-fungal Agents Market
10.3.6.3.1 India Anti-fungal Agents Market by Drug Type
10.3.6.3.2 India Anti-fungal Agents Market by Therapeutic Indication
10.3.6.3.3 India Anti-fungal Agents Market by Dosage form
10.3.6.4 Japan Anti-fungal Agents Market
10.3.6.4.1 Japan Anti-fungal Agents Market by Drug Type
10.3.6.4.2 Japan Anti-fungal Agents Market by Therapeutic Indication
10.3.6.4.3 Japan Anti-fungal Agents Market by Dosage form
10.3.6.5 South Korea Anti-fungal Agents Market
10.3.6.5.1 South Korea Anti-fungal Agents Market by Drug Type
10.3.6.5.2 South Korea Anti-fungal Agents Market by Therapeutic Indication
10.3.6.5.3 South Korea Anti-fungal Agents Market by Dosage form
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Anti-fungal Agents Market Overview
10.4.2 Middle East and Africa Anti-fungal Agents Market Forecasts and Analysis
10.4.3 Middle East and Africa Anti-fungal Agents Market Forecasts and Analysis - By Drug Type
10.4.4 Middle East and Africa Anti-fungal Agents Market Forecasts and Analysis - By Therapeutic Indication
10.4.5 Middle East and Africa Anti-fungal Agents Market Forecasts and Analysis - By Dosage form
10.4.6 Middle East and Africa Anti-fungal Agents Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Anti-fungal Agents Market
10.4.6.1.1 South Africa Anti-fungal Agents Market by Drug Type
10.4.6.1.2 South Africa Anti-fungal Agents Market by Therapeutic Indication
10.4.6.1.3 South Africa Anti-fungal Agents Market by Dosage form
10.4.6.2 Saudi Arabia Anti-fungal Agents Market
10.4.6.2.1 Saudi Arabia Anti-fungal Agents Market by Drug Type
10.4.6.2.2 Saudi Arabia Anti-fungal Agents Market by Therapeutic Indication
10.4.6.2.3 Saudi Arabia Anti-fungal Agents Market by Dosage form
10.4.6.3 U.A.E Anti-fungal Agents Market
10.4.6.3.1 U.A.E Anti-fungal Agents Market by Drug Type
10.4.6.3.2 U.A.E Anti-fungal Agents Market by Therapeutic Indication
10.4.6.3.3 U.A.E Anti-fungal Agents Market by Dosage form
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Anti-fungal Agents Market Overview
10.5.2 South and Central America Anti-fungal Agents Market Forecasts and Analysis
10.5.3 South and Central America Anti-fungal Agents Market Forecasts and Analysis - By Drug Type
10.5.4 South and Central America Anti-fungal Agents Market Forecasts and Analysis - By Therapeutic Indication
10.5.5 South and Central America Anti-fungal Agents Market Forecasts and Analysis - By Dosage form
10.5.6 South and Central America Anti-fungal Agents Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Anti-fungal Agents Market
10.5.6.1.1 Brazil Anti-fungal Agents Market by Drug Type
10.5.6.1.2 Brazil Anti-fungal Agents Market by Therapeutic Indication
10.5.6.1.3 Brazil Anti-fungal Agents Market by Dosage form
10.5.6.2 Argentina Anti-fungal Agents Market
10.5.6.2.1 Argentina Anti-fungal Agents Market by Drug Type
10.5.6.2.2 Argentina Anti-fungal Agents Market by Therapeutic Indication
10.5.6.2.3 Argentina Anti-fungal Agents Market by Dosage form

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. ANTI-FUNGAL AGENTS MARKET, KEY COMPANY PROFILES
12.1. ABBOTT LABORATORIES, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ZYDUS CADILA HEALTHCARE LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ASTELLAS PHARMA, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BASILEA PHARMACEUTICA AG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BAYER HEALTHCARE LLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BRISTOL-MYERS SQUIBB PHARMACEUTICALS, LTD.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. TEVA PHARMACEUTICAL INDUSTRIES, LTD.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SUN PHARMACEUTICAL INDUSTRIES, LTD.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MYLAN PHARMACEUTICALS, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1.Abbott Laboratories, Inc.
2.Zydus Cadila Healthcare Ltd.
3.Astellas Pharma, Inc.
4.Basilea Pharmaceutica AG
5.Bayer Healthcare LLC
6.Bristol-Myers Squibb Pharmaceuticals, Ltd.
7.Teva Pharmaceutical Industries, Ltd.
8.Sun Pharmaceutical Industries, Ltd.
9.Pfizer, Inc.
10.Mylan Pharmaceuticals, Inc.
TIPRE00008775
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550 $4095
  • $6550 $5568
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount